Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

被引：0
|
作者：
Xiao-yan Qiu
Zheng Jiao
Ming Zhang
Long-jin Zhong
Hui-qi Liang
Chun-lai Ma
Liang Zhang
Ming-kang Zhong
机构：
[1] Fudan University,Clinical Pharmacy Laboratory, Huashan Hospital
[2] Fudan University,School of Pharmacy
[3] Fudan University,Department of Nephrology, Huashan Hospital
来源：
European Journal of Clinical Pharmacology | 2008年 / 64卷
关键词：
MDR1; CYP3A4*18B; CYP3A5*3; Cyclosporine; Renal transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients
    Sharaki, Ola
    Zeid, Montasser
    Moez, Pacint
    Zakaria, Nermine Hossam
    Nassar, Eman
    MOLECULAR BIOLOGY REPORTS, 2015, 42 (01) : 105 - 117
  • [22] Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients
    Ola Sharaki
    Montasser Zeid
    Pacint Moez
    Nermine Hossam Zakaria
    Eman Nassar
    Molecular Biology Reports, 2015, 42 : 105 - 117
  • [23] Effect of CYP3A4 and CYP3A5 Genetic Polymorphisms on the Pharmacokinetics of Sirolimus in Healthy Chinese Volunteers
    Zhang, Jing
    Dai, Ying
    Liu, Zhihong
    Zhang, Minxin
    Li, Chen
    Chen, Dingxiong
    Song, Hongtao
    THERAPEUTIC DRUG MONITORING, 2017, 39 (04) : 406 - 411
  • [24] Association of CYP3A5 genotype with the metabolic ratio (MR) of cyclosporine in Chinese renal transplant recipients
    Chu, Xiao-man
    Guo, Lian-qin
    Min, Pei-qing
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 235 - 235
  • [25] Significant impacts of CYP3A4*1G and CYP3A5*3 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients
    Zhou, L. -Y.
    Zuo, X. -C.
    Chen, K.
    Wang, J. -L.
    Chen, Q. -J.
    Zhou, Y. -N.
    Yuan, H.
    Ma, Y.
    Zhu, L. -J.
    Peng, Y. -X.
    Ming, Y. -Z.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (03) : 341 - 347
  • [26] CYP3A5*3, CYP3A4*1B and MDR1 C3435T genotype distributions in Ecuadorians
    Sinues, Blanca
    Vicente, Jorge
    Fanlo, Ana
    Mayayo-Sinues, Esteban
    Gonzalez-Andrade, Fabricio
    Sanchez-Q, Dora
    Martinez-Jarreta, Begona
    DISEASE MARKERS, 2008, 24 (06) : 325 - 331
  • [27] Effect of CYP3A4, CYP3A5, MDR1 and POR Genetic Polymorphisms in Immunosuppressive Treatment in Chilean Kidney Transplanted Patients
    Contreras-Castillo, Stephania
    Plaza, Anita
    Stojanova, Jana
    Navarro, Gustavo
    Carmona, Rodolfo
    Corvalan, Fernando
    Cerpa, Leslie
    Sandoval, Christopher
    Munoz, Daniel
    Leiva, Marina
    Castaneda, Luis E.
    Farias, Nayaret
    Alvarez, Carolina
    Llull, Gabriel
    Mezzano, Sergio
    Ardiles, Leopoldo
    Varela, Nelson
    Rodriguez, Maria S.
    Flores, Claudio
    Cayun, Juan Pablo
    Krall, Paola
    Quinones, Luis A.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [28] Effects of CYP3A4*1G and CYP3A5*3 polymorphisms on pharmacokinetics of tylerdipine hydrochloride in healthy Chinese subjects
    Zhou, Sufeng
    Tao, Mingxue
    Wang, Yuanyuan
    Wang, Lu
    Xie, Lijun
    Chen, Juan
    Zhao, Yuqing
    Liu, Yun
    Zhang, Hongwen
    Ou, Ning
    Wang, Guangji
    Shao, Feng
    Aa, Jiye
    XENOBIOTICA, 2019, 49 (03) : 375 - 380
  • [29] CYP3A4 genetic polymorphisms predict cyclosporine-related clinical events in Chinese renal transplant recipients
    Wang Yu-yuan
    Zhang Ming
    Lu Fu-ming
    Jiao Zheng
    Qiu Xiao-yan
    CHINESE MEDICAL JOURNAL, 2012, 125 (23) : 4233 - 4238
  • [30] The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients
    Yates, CR
    Zhang, WH
    Song, PF
    Li, S
    Gaber, AO
    Kotb, M
    Honaker, MR
    Alloway, RR
    Meibohm, B
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (06) : 555 - 564
12345